| Symbol | Genename | TEL-AML1 score | other score |
---|
36239_at | POU2AF1 | POU domain, class 2, associating factor 1 | 0.9773 | -0.3113 |
---|
33162_at | INSR | insulin receptor | 0.7026 | -0.2238 |
---|
36638_at | CTGF | connective tissue growth factor | 0.6605 | -0.2104 |
---|
40570_at | FOXO1A | forkhead box O1A (rhabdomyosarcoma) | 0.6508 | -0.2073 |
---|
1779_s_at | PIM1 | pim-1 oncogene | 0.6227 | -0.1984 |
---|
34481_at | VAV1 | vav 1 oncogene | 0.6079 | -0.1936 |
---|
34525_at | TCL1B | T-cell leukemia/lymphoma 1B | 0.5793 | -0.1845 |
---|
40367_at | BMP2 | bone morphogenetic protein 2 | 0.5656 | -0.1802 |
---|
883_s_at | PIM1 | pim-1 oncogene | 0.537 | -0.1711 |
---|
1113_at | BMP2 | bone morphogenetic protein 2 | 0.5143 | -0.1638 |
---|
1919_at | VAV1 | vav 1 oncogene | 0.4325 | -0.1378 |
---|
40019_at | EVI2B | ecotropic viral integration site 2B | -0.3964 | 0.1263 |
---|
33387_at | GAS7 | growth arrest-specific 7 | -0.372 | 0.1185 |
---|
41175_at | CBFB | core-binding factor, beta subunit | -0.3597 | 0.1146 |
---|
1572_s_at | INSR | insulin receptor | 0.3475 | -0.1107 |
---|
37194_at | GATA2 | GATA binding protein 2 | 0.3423 | -0.109 |
---|
40480_s_at | FYN | FYN oncogene related to SRC, FGR, YES | -0.3412 | 0.1087 |
---|
32874_at | TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.3277 | -0.1044 |
---|
1915_s_at | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog | -0.3198 | 0.1019 |
---|
2039_s_at | FYN | FYN oncogene related to SRC, FGR, YES | -0.3179 | 0.1013 |
---|
39712_at | S100A13 | S100 calcium binding protein A13 | -0.3142 | 0.1001 |
---|
34299_at | ZNF278 | zinc finger protein 278 | 0.3098 | -0.0987 |
---|
40091_at | BCL6 | B-cell CLL/lymphoma 6 (zinc finger protein 51) | -0.3096 | 0.0986 |
---|
36805_s_at | NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.2982 | -0.095 |
---|
1892_s_at | TPM3 | tropomyosin 3 | 0.2949 | -0.0939 |
---|
840_at | MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | 0.2894 | -0.0922 |
---|
1916_s_at | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog | -0.2888 | 0.092 |
---|
2094_s_at | FOS | v-fos FBJ murine osteosarcoma viral oncogene homolog | -0.2817 | 0.0897 |
---|
1856_at | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.2684 | -0.0855 |
---|
35340_at | RAB8A | RAB8A, member RAS oncogene family | -0.2595 | 0.0827 |
---|
32184_at | LMO2 | LIM domain only 2 (rhombotin-like 1) | -0.2582 | 0.0822 |
---|
1826_at | ARHB | ras homolog gene family, member B | -0.2554 | 0.0813 |
---|
1782_s_at | STMN1 | stathmin 1/oncoprotein 18 | 0.2543 | -0.081 |
---|
34316_at | CDR1 | cerebellar degeneration-related protein 1, 34kDa | -0.2528 | 0.0805 |
---|
40412_at | PTTG1 | pituitary tumor-transforming 1 | -0.2508 | 0.0799 |
---|
39318_at | TCL1A | T-cell leukemia/lymphoma 1A | 0.2381 | -0.0759 |
---|
1373_at | TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.2366 | -0.0754 |
---|
39159_at | SH3GL1 | SH3-domain GRB2-like 1 | 0.2282 | -0.0727 |
---|
38992_at | DEK | DEK oncogene (DNA binding) | -0.2258 | 0.0719 |
---|
40189_at | SET | SET translocation (myeloid leukemia-associated) | -0.2236 | 0.0712 |
---|
2059_s_at | LCK | lymphocyte-specific protein tyrosine kinase | -0.2176 | 0.0693 |
---|
1706_at | ARAF1 | v-raf murine sarcoma 3611 viral oncogene homolog 1 | -0.2169 | 0.0691 |
---|
361_at | BCL9 | B-cell CLL/lymphoma 9 | 0.2118 | -0.0675 |
---|
31526_f_at | USP6 | ubiquitin specific protease 6 (Tre-2 oncogene) | 0.2102 | -0.0669 |
---|
33238_at | LCK | lymphocyte-specific protein tyrosine kinase | -0.207 | 0.066 |
---|
37663_at | DDX1 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 | -0.2018 | 0.0643 |
---|
33253_at | TRIM14 | tripartite motif-containing 14 | -0.2007 | 0.0639 |
---|
34300_at | ZNF278 | zinc finger protein 278 | 0.1961 | -0.0625 |
---|
1394_at | ARHA | ras homolog gene family, member A | -0.1903 | 0.0606 |
---|
203_at | GATA2 | GATA binding protein 2 | 0.1866 | -0.0594 |
---|
40203_at | SUI1 | putative translation initiation factor | -0.183 | 0.0583 |
---|
41504_s_at | MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | -0.1797 | 0.0572 |
---|
36120_at | FVT1 | follicular lymphoma variant translocation 1 | -0.178 | 0.0567 |
---|
1374_g_at | TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.1761 | -0.0561 |
---|
38118_at | SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | -0.1724 | 0.0549 |
---|
36951_at | MRPL49 | mitochondrial ribosomal protein L49 | 0.171 | -0.0545 |
---|
1786_at | MERTK | c-mer proto-oncogene tyrosine kinase | -0.1709 | 0.0544 |
---|
32063_at | PBX1 | pre-B-cell leukemia transcription factor 1 | -0.1707 | 0.0544 |
---|
33355_at | PBX1 | pre-B-cell leukemia transcription factor 1 | -0.1691 | 0.0539 |
---|
35339_at | RAB8A | RAB8A, member RAS oncogene family | -0.1679 | 0.0535 |
---|
37309_at | ARHA | ras homolog gene family, member A | -0.1644 | 0.0524 |
---|
37448_s_at | GNAS | GNAS complex locus | 0.1582 | -0.0504 |
---|
1707_g_at | ARAF1 | v-raf murine sarcoma 3611 viral oncogene homolog 1 | -0.1565 | 0.0499 |
---|
34317_g_at | CDR1 | cerebellar degeneration-related protein 1, 34kDa | -0.1547 | 0.0493 |
---|
36592_at | PHB | prohibitin | -0.1545 | 0.0492 |
---|
1476_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.1534 | 0.0489 |
---|
1473_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.1503 | 0.0479 |
---|
37339_at | USP4 | ubiquitin specific protease 4 (proto-oncogene) | -0.1496 | 0.0476 |
---|
39421_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.1485 | -0.0473 |
---|
943_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.1473 | -0.0469 |
---|
31663_at | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.1452 | -0.0463 |
---|
1675_at | RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | -0.1422 | 0.0453 |
---|
39511_at | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.1411 | -0.045 |
---|
34669_at | TFE3 | transcription factor binding to IGHM enhancer 3 | -0.1407 | 0.0448 |
---|
1796_s_at | BCL3 | B-cell CLL/lymphoma 3 | 0.1393 | -0.0444 |
---|
40648_at | MERTK | c-mer proto-oncogene tyrosine kinase | -0.1392 | 0.0443 |
---|
477_at | IRF5 | interferon regulatory factor 5 | 0.1349 | -0.043 |
---|
37450_r_at | GNAS | GNAS complex locus | 0.1338 | -0.0426 |
---|
38219_at | CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.1337 | -0.0426 |
---|
37449_i_at | GNAS | GNAS complex locus | 0.133 | -0.0424 |
---|
2042_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.1325 | 0.0422 |
---|
1071_at | GATA2 | GATA binding protein 2 | 0.1303 | -0.0415 |
---|
1474_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.1302 | 0.0415 |
---|
719_g_at | PRSS11 | protease, serine, 11 (IGF binding) | 0.1299 | -0.0414 |
---|
36935_at | RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | -0.1287 | 0.041 |
---|
255_s_at | INHA | inhibin, alpha | -0.1285 | 0.0409 |
---|
37809_at | HOXA9 | homeo box A9 | -0.1284 | 0.0409 |
---|
772_at | CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.1283 | -0.0409 |
---|
35772_at | ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.123 | -0.0392 |
---|
1475_s_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.122 | 0.0389 |
---|
1472_g_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.1218 | 0.0388 |
---|
1547_at | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 0.1209 | -0.0385 |
---|
1674_at | YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.1209 | -0.0385 |
---|
40957_at | JJAZ1 | joined to JAZF1 | -0.1203 | 0.0383 |
---|
39149_at | PRCC | papillary renal cell carcinoma (translocation-associated) | -0.1194 | 0.038 |
---|
1518_at | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.1185 | -0.0377 |
---|
1940_at | KRAS2 | v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog | -0.1181 | 0.0376 |
---|
126_s_at | SSX2 | synovial sarcoma, X breakpoint 2 | 0.118 | -0.0376 |
---|
40479_at | FYN | FYN oncogene related to SRC, FGR, YES | -0.1174 | 0.0374 |
---|
36594_s_at | EXT2 | exostoses (multiple) 2 | -0.117 | 0.0373 |
---|
35629_at | MKL1 | megakaryoblastic leukemia (translocation) 1 | -0.1166 | 0.0371 |
---|
36593_at | EXT2 | exostoses (multiple) 2 | -0.1146 | 0.0365 |
---|
39989_at | RRAGB | Ras-related GTP binding B | -0.1132 | 0.0361 |
---|
32583_at | JUN | v-jun sarcoma virus 17 oncogene homolog (avian) | -0.1122 | 0.0357 |
---|
1072_g_at | GATA2 | GATA binding protein 2 | 0.1121 | -0.0357 |
---|
393_s_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.1072 | -0.0341 |
---|
38509_at | MDM2 | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | 0.1064 | -0.0339 |
---|
39350_at | GPC3 | glypican 3 | 0.1046 | -0.0333 |
---|
1333_f_at | BCR | breakpoint cluster region | -0.1035 | 0.033 |
---|
32827_at | RRAS2 | related RAS viral (r-ras) oncogene homolog 2 | 0.1032 | -0.0329 |
---|
34663_at | FCGR2B | Fc fragment of IgG, low affinity IIb, receptor for (CD32) | -0.1026 | 0.0327 |
---|
41339_at | UBE4B | ubiquitination factor E4B (UFD2 homolog, yeast) | -0.1026 | 0.0327 |
---|
567_s_at | PML | promyelocytic leukemia | 0.1025 | -0.0326 |
---|
40659_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.1024 | -0.0326 |
---|
2038_g_at | BCL2 | B-cell CLL/lymphoma 2 | -0.1012 | 0.0323 |
---|
38788_at | PML | promyelocytic leukemia | 0.1009 | -0.0321 |
---|
41505_r_at | MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | -0.1006 | 0.032 |
---|
40481_r_at | FYN | FYN oncogene related to SRC, FGR, YES | -0.1006 | 0.032 |
---|
35641_g_at | CBFA2T1 | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | 0.1001 | -0.0319 |
---|
1638_at | ETV6 | ets variant gene 6 (TEL oncogene) | -0.0993 | 0.0316 |
---|
39681_at | ZNF145 | zinc finger protein 145 (Kruppel-like, expressed in promyelocytic leukemia) | 0.0978 | -0.0312 |
---|
2006_at | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | 0.0961 | -0.0306 |
---|
38650_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0956 | 0.0304 |
---|
1257_s_at | QSCN6 | quiescin Q6 | -0.0939 | 0.0299 |
---|
1736_at | IGFBP6 | insulin-like growth factor binding protein 6 | -0.0928 | 0.0296 |
---|
35316_at | RRAGA | Ras-related GTP binding A | -0.0923 | 0.0294 |
---|
40362_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.0915 | -0.0291 |
---|
39174_at | NCOA4 | nuclear receptor coactivator 4 | -0.0899 | 0.0286 |
---|
478_g_at | IRF5 | interferon regulatory factor 5 | -0.0889 | 0.0283 |
---|
1780_at | FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | -0.0885 | 0.0282 |
---|
33474_at | GLI | glioma-associated oncogene homolog (zinc finger protein) | -0.0881 | 0.0281 |
---|
31798_at | TFF1 | trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in) | 0.087 | -0.0277 |
---|
38813_at | TSC2 | tuberous sclerosis 2 | 0.0851 | -0.0271 |
---|
40661_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.0839 | -0.0267 |
---|
38140_at | EXTL1 | exostoses (multiple)-like 1 | 0.0833 | -0.0265 |
---|
36941_at | AF1Q | ALL1-fused gene from chromosome 1q | 0.0831 | -0.0265 |
---|
1341_at | SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | -0.083 | 0.0264 |
---|
2043_s_at | BCR | breakpoint cluster region | -0.0827 | 0.0263 |
---|
33850_at | SUI1 | putative translation initiation factor | -0.0818 | 0.0261 |
---|
1741_s_at | IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | -0.081 | 0.0258 |
---|
37846_at | GRAF | GTPase regulator associated with focal adhesion kinase pp125(FAK) | 0.0804 | -0.0256 |
---|
718_at | PRSS11 | protease, serine, 11 (IGF binding) | 0.0796 | -0.0254 |
---|
1613_s_at | USP6 | ubiquitin specific protease 6 (Tre-2 oncogene) | -0.0796 | 0.0254 |
---|
2017_s_at | CCND1 | cyclin D1 (PRAD1 | 0.0795 | -0.0253 |
---|
40422_at | IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | -0.0788 | 0.0251 |
---|
423_at | EWSR1 | Ewing sarcoma breakpoint region 1 | -0.0787 | 0.0251 |
---|
38545_at | INHBB | inhibin, beta B (activin AB beta polypeptide) | -0.0784 | 0.025 |
---|
33884_s_at | UBE4B | ubiquitination factor E4B (UFD2 homolog, yeast) | -0.0782 | 0.0249 |
---|
35608_at | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.0781 | -0.0249 |
---|
1909_at | BCL2 | B-cell CLL/lymphoma 2 | 0.078 | -0.0248 |
---|
2008_s_at | MDM2 | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | 0.0764 | -0.0243 |
---|
774_g_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | 0.0764 | -0.0243 |
---|
40660_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.0746 | -0.0238 |
---|
1232_s_at | IGFBP1 | insulin-like growth factor binding protein 1 | 0.0741 | -0.0236 |
---|
1344_at | PAX3 | paired box gene 3 (Waardenburg syndrome 1) | 0.0741 | -0.0236 |
---|
773_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | 0.073 | -0.0233 |
---|
780_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.0728 | -0.0232 |
---|
34740_at | FOXO3A | forkhead box O3A | -0.0721 | 0.023 |
---|
36471_f_at | DTNA | dystrobrevin, alpha | 0.071 | -0.0226 |
---|
735_s_at | AKAP13 | A kinase (PRKA) anchor protein 13 | -0.0709 | 0.0226 |
---|
37279_at | GEM | GTP binding protein overexpressed in skeletal muscle | 0.0701 | -0.0223 |
---|
545_g_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.0693 | -0.0221 |
---|
1837_at | RRAS2 | related RAS viral (r-ras) oncogene homolog 2 | 0.0687 | -0.0219 |
---|
1859_s_at | MDM2 | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | 0.0685 | -0.0218 |
---|
2007_g_at | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | -0.0682 | 0.0217 |
---|
37461_at | ANGPT2 | angiopoietin 2 | -0.0679 | 0.0216 |
---|
41105_s_at | MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.0677 | -0.0216 |
---|
1838_g_at | RRAS2 | related RAS viral (r-ras) oncogene homolog 2 | 0.0675 | -0.0215 |
---|
638_at | HMGA2 | high mobility group AT-hook 2 | -0.0674 | 0.0215 |
---|
38639_at | MXD4 | MAX dimerization protein 4 | -0.0672 | 0.0214 |
---|
34770_at | MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.0654 | -0.0208 |
---|
36437_s_at | RANBP9 | RAN binding protein 9 | -0.0648 | 0.0206 |
---|
31609_s_at | PCOLCE | procollagen C-endopeptidase enhancer | 0.064 | -0.0204 |
---|
2078_s_at | MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | -0.0639 | 0.0203 |
---|
41069_at | LECT1 | leukocyte cell derived chemotaxin 1 | 0.0639 | -0.0203 |
---|
36409_f_at | SSX2 | synovial sarcoma, X breakpoint 2 | 0.0633 | -0.0202 |
---|
31631_f_at | PTTG2 | pituitary tumor-transforming 2 | -0.063 | 0.0201 |
---|
1866_g_at | SKIL | SKI-like | 0.0628 | -0.02 |
---|
38418_at | CCND1 | cyclin D1 (PRAD1 | 0.0626 | -0.0199 |
---|
41571_at | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.0624 | -0.0199 |
---|
767_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | 0.0621 | -0.0198 |
---|
41420_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.062 | 0.0197 |
---|
36469_at | DTNA | dystrobrevin, alpha | 0.0602 | -0.0192 |
---|
841_at | OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.0595 | -0.019 |
---|
40332_at | OGFR | opioid growth factor receptor | 0.0593 | -0.0189 |
---|
1853_at | WNT1 | wingless-type MMTV integration site family, member 1 | -0.0587 | 0.0187 |
---|
40357_at | INHBA | inhibin, beta A (activin A, activin AB alpha polypeptide) | -0.0584 | 0.0186 |
---|
32694_at | RARB | retinoic acid receptor, beta | 0.0581 | -0.0185 |
---|
593_s_at | ROS1 | v-ros UR2 sarcoma virus oncogene homolog 1 (avian) | 0.0579 | -0.0184 |
---|
1237_at | IER3 | immediate early response 3 | -0.0578 | 0.0184 |
---|
34679_at | BCR | breakpoint cluster region | -0.0575 | 0.0183 |
---|
702_f_at | HSHPX5 | HPX-5 | 0.0549 | -0.0175 |
---|
36470_s_at | DTNA | dystrobrevin, alpha | 0.0547 | -0.0174 |
---|
41572_r_at | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.0536 | -0.0171 |
---|
37829_at | GAS2 | growth arrest-specific 2 | -0.0533 | 0.017 |
---|
1357_at | USP4 | ubiquitin specific protease 4 (proto-oncogene) | -0.0532 | 0.017 |
---|
38787_at | PML | promyelocytic leukemia | 0.0526 | -0.0167 |
---|
1601_s_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0512 | 0.0163 |
---|
38809_s_at | EXTL3 | exostoses (multiple)-like 3 | -0.0509 | 0.0162 |
---|
1895_at | JUN | v-jun sarcoma virus 17 oncogene homolog (avian) | -0.05 | 0.0159 |
---|
41500_at | SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.0497 | -0.0158 |
---|
35638_at | CBFA2T1 | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | 0.0494 | -0.0157 |
---|
32582_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | -0.049 | 0.0156 |
---|
1538_s_at | IL2 | interleukin 2 | 0.0488 | -0.0155 |
---|
37162_at | CCDC6 | coiled-coil domain containing 6 | -0.0478 | 0.0152 |
---|
1678_g_at | IGFBP5 | insulin-like growth factor binding protein 5 | 0.0475 | -0.0151 |
---|
38544_at | INHA | inhibin, alpha | 0.0466 | -0.0148 |
---|
544_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.0465 | -0.0148 |
---|
34665_g_at | FCGR2B | Fc fragment of IgG, low affinity IIb, receptor for (CD32) | -0.0465 | 0.0148 |
---|
888_s_at | GDF1 | growth differentiation factor 1 | 0.0456 | -0.0145 |
---|
38739_at | ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.0453 | -0.0144 |
---|
1847_s_at | BCL2 | B-cell CLL/lymphoma 2 | 0.0451 | -0.0144 |
---|
1396_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0451 | 0.0144 |
---|
32754_at | TPM3 | tropomyosin 3 | 0.0445 | -0.0142 |
---|
32018_at | BCAS4 | breast carcinoma amplified sequence 4 | -0.0444 | 0.0141 |
---|
535_s_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | -0.044 | 0.014 |
---|
35915_at | INHBC | inhibin, beta C | 0.0439 | -0.014 |
---|
36466_at | DTNA | dystrobrevin, alpha | 0.0435 | -0.0139 |
---|
1337_s_at | RARA | retinoic acid receptor, alpha | -0.0434 | 0.0138 |
---|
559_s_at | TLX1 | T-cell leukemia, homeobox 1 | -0.0424 | 0.0135 |
---|
40624_at | OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.0423 | -0.0135 |
---|
36238_at | MLLT7 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7 | 0.0412 | -0.0131 |
---|
41854_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | -0.0412 | 0.0131 |
---|
35147_at | MCF2L | MCF.2 cell line derived transforming sequence-like | 0.0409 | -0.013 |
---|
1806_at | MCF2 | MCF.2 cell line derived transforming sequence | 0.0408 | -0.013 |
---|
31779_s_at | PRDM1 | PR domain containing 1, with ZNF domain | 0.0405 | -0.0129 |
---|
33773_at | MLLT10 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 | 0.0403 | -0.0129 |
---|
34324_at | CLN5 | ceroid-lipofuscinosis, neuronal 5 | 0.0398 | -0.0127 |
---|
37664_at | DRG2 | developmentally regulated GTP binding protein 2 | -0.0397 | 0.0127 |
---|
36465_at | IRF5 | interferon regulatory factor 5 | -0.0393 | 0.0125 |
---|
34416_at | CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | -0.0387 | 0.0123 |
---|
1888_s_at | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.0376 | -0.012 |
---|
37810_at | HOXA9 | homeo box A9 | -0.0376 | 0.012 |
---|
34379_at | ERAL1 | Era G-protein-like 1 (E. coli) | -0.0375 | 0.0119 |
---|
33043_at | USP6 | ubiquitin specific protease 6 (Tre-2 oncogene) | 0.0373 | -0.0119 |
---|
38377_at | MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | -0.0372 | 0.0118 |
---|
1951_at | ANGPT2 | angiopoietin 2 | -0.037 | 0.0118 |
---|
1203_at | INHBA | inhibin, beta A (activin A, activin AB alpha polypeptide) | -0.0365 | 0.0116 |
---|
32960_at | SMO | smoothened homolog (Drosophila) | 0.0364 | -0.0116 |
---|
940_g_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 0.0364 | -0.0116 |
---|
35044_i_at | BMP8B | bone morphogenetic protein 8b (osteogenic protein 2) | 0.0363 | -0.0116 |
---|
38627_at | HLF | hepatic leukemia factor | 0.036 | -0.0115 |
---|
1891_at | MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.0351 | -0.0112 |
---|
37310_at | PLAU | plasminogen activator, urokinase | 0.0346 | -0.011 |
---|
40977_f_at | CDR1 | cerebellar degeneration-related protein 1, 34kDa | 0.0341 | -0.0109 |
---|
739_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | -0.034 | 0.0108 |
---|
38491_at | ETV6 | ets variant gene 6 (TEL oncogene) | -0.0337 | 0.0108 |
---|
401_s_at | HLF | hepatic leukemia factor | 0.0335 | -0.0107 |
---|
31399_at | BMP10 | bone morphogenetic protein 10 | -0.0334 | 0.0106 |
---|
35133_at | FER | fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94) | 0.0331 | -0.0105 |
---|
35200_at | HMGA2 | high mobility group AT-hook 2 | 0.0331 | -0.0105 |
---|
41620_at | DOCK4 | dedicator of cytokinesis 4 | 0.0329 | -0.0105 |
---|
38289_r_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 0.0327 | -0.0104 |
---|
40363_r_at | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.0326 | -0.0104 |
---|
41562_at | BMI1 | B lymphoma Mo-MLV insertion region (mouse) | 0.0325 | -0.0103 |
---|
978_at | BCL6 | B-cell CLL/lymphoma 6 (zinc finger protein 51) | 0.0321 | -0.0102 |
---|
40575_at | DLG5 | discs, large homolog 5 (Drosophila) | -0.0321 | 0.0102 |
---|
1677_at | IGFBP5 | insulin-like growth factor binding protein 5 | -0.0317 | 0.0101 |
---|
40312_at | DACH | dachshund homolog (Drosophila) | -0.0312 | 0.0099 |
---|
41499_at | SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.0308 | -0.0098 |
---|
39935_at | SKIL | SKI-like | 0.0305 | -0.0097 |
---|
40044_at | ELL | elongation factor RNA polymerase II | -0.0304 | 0.0097 |
---|
887_at | GDF1 | growth differentiation factor 1 | -0.0301 | 0.0096 |
---|
1865_at | SKIL | SKI-like | -0.0299 | 0.0095 |
---|
1339_s_at | BCR | breakpoint cluster region | 0.0298 | -0.0095 |
---|
35328_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 0.0297 | -0.0095 |
---|
37319_at | IGFBP3 | insulin-like growth factor binding protein 3 | 0.0295 | -0.0094 |
---|
34664_at | FCGR2B | Fc fragment of IgG, low affinity IIb, receptor for (CD32) | 0.0289 | -0.0092 |
---|
1490_at | MYCL1 | v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) | 0.0286 | -0.0091 |
---|
31872_at | SS18 | synovial sarcoma translocation, chromosome 18 | 0.0279 | -0.0089 |
---|
1174_at | MOS | v-mos Moloney murine sarcoma viral oncogene homolog | -0.0276 | 0.0088 |
---|
36920_at | MTM1 | myotubular myopathy 1 | 0.0276 | -0.0088 |
---|
33900_at | FSTL3 | follistatin-like 3 (secreted glycoprotein) | -0.0275 | 0.0088 |
---|
1084_at | ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene) | 0.0274 | -0.0087 |
---|
2005_s_at | JAK3 | Janus kinase 3 (a protein tyrosine kinase, leukocyte) | -0.0265 | 0.0085 |
---|
1614_s_at | USP6 | ubiquitin specific protease 6 (Tre-2 oncogene) | 0.0265 | -0.0084 |
---|
1586_at | IGFBP3 | insulin-like growth factor binding protein 3 | 0.0261 | -0.0083 |
---|
35640_at | CBFA2T1 | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | -0.0257 | 0.0082 |
---|
1395_at | ARHC | ras homolog gene family, member C | 0.0255 | -0.0081 |
---|
35975_at | MLLT3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 | -0.0242 | 0.0077 |
---|
36283_at | DDX6 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 | 0.024 | -0.0076 |
---|
31874_at | GAS2L1 | growth arrest-specific 2 like 1 | 0.0237 | -0.0076 |
---|
1743_s_at | SKIL | SKI-like | -0.0236 | 0.0075 |
---|
1236_s_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | -0.0234 | 0.0075 |
---|
32164_at | EXT1 | exostoses (multiple) 1 | 0.023 | -0.0073 |
---|
377_g_at | SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.0229 | -0.0073 |
---|
32963_s_at | RRAGD | Ras-related GTP binding D | 0.0228 | -0.0073 |
---|
2060_at | BCL2 | B-cell CLL/lymphoma 2 | 0.0223 | -0.0071 |
---|
871_s_at | HLF | hepatic leukemia factor | 0.0221 | -0.007 |
---|
2026_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | -0.0212 | 0.0067 |
---|
32474_at | PAX7 | paired box gene 7 | 0.0209 | -0.0067 |
---|
1539_at | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | -0.0206 | 0.0066 |
---|
566_at | PML | promyelocytic leukemia | -0.0196 | 0.0062 |
---|
35563_at | MKL1 | megakaryoblastic leukemia (translocation) 1 | -0.0195 | 0.0062 |
---|
1880_at | MDM2 | Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) | 0.0194 | -0.0062 |
---|
37468_at | JAK2 | Janus kinase 2 (a protein tyrosine kinase) | -0.0183 | 0.0058 |
---|
32359_at | WISP1 | WNT1 inducible signaling pathway protein 1 | -0.0179 | 0.0057 |
---|
34068_f_at | SSX1 | synovial sarcoma, X breakpoint 1 | 0.0178 | -0.0057 |
---|
1623_s_at | FER | fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94) | 0.0173 | -0.0055 |
---|
32399_at | EVI1 | ecotropic viral integration site 1 | -0.0169 | 0.0054 |
---|
376_at | SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | -0.0167 | 0.0053 |
---|
1882_g_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | -0.0167 | 0.0053 |
---|
1910_s_at | BCL2 | B-cell CLL/lymphoma 2 | -0.0166 | 0.0053 |
---|
38420_at | COL5A2 | collagen, type V, alpha 2 | -0.0161 | 0.0051 |
---|
39547_at | RANBP9 | RAN binding protein 9 | -0.0159 | 0.0051 |
---|
1471_at | MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 0.0153 | -0.0049 |
---|
32159_at | KRAS2 | v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog | 0.0151 | -0.0048 |
---|
31392_r_at | C1orf1 | chromosome 1 open reading frame 1 | -0.0149 | 0.0047 |
---|
35673_at | ARHGEF5 | Rho guanine nucleotide exchange factor (GEF) 5 | 0.0143 | -0.0046 |
---|
190_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.0142 | -0.0045 |
---|
34069_s_at | SSX2 | synovial sarcoma, X breakpoint 2 | 0.014 | -0.0045 |
---|
37407_s_at | MYH11 | myosin, heavy polypeptide 11, smooth muscle | 0.0138 | -0.0044 |
---|
1124_at | MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | -0.0137 | 0.0044 |
---|
1590_s_at | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | -0.0134 | 0.0043 |
---|
36674_at | CCL4 | chemokine (C-C motif) ligand 4 | 0.0128 | -0.0041 |
---|
36467_g_at | DTNA | dystrobrevin, alpha | 0.0127 | -0.004 |
---|
40978_s_at | CDR1 | cerebellar degeneration-related protein 1, 34kDa | -0.012 | 0.0038 |
---|
36468_at | DTNA | dystrobrevin, alpha | 0.0117 | -0.0037 |
---|
1489_s_at | MYCL1 | v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian) | 0.0117 | -0.0037 |
---|
35701_at | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | -0.0117 | 0.0037 |
---|
1519_at | ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.0112 | -0.0036 |
---|
961_at | NF1 | neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease) | 0.01 | -0.0032 |
---|
160028_s_at | RET | ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) | -0.0091 | 0.0029 |
---|
37685_at | PICALM | phosphatidylinositol binding clathrin assembly protein | -0.0081 | 0.0026 |
---|
1345_s_at | PAX3 | paired box gene 3 (Waardenburg syndrome 1) | 0.0072 | -0.0023 |
---|
222_at | EXT1 | exostoses (multiple) 1 | 0.007 | -0.0022 |
---|
1977_s_at | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | -0.0066 | 0.0021 |
---|
34021_at | IL2 | interleukin 2 | -0.0066 | 0.0021 |
---|
40662_g_at | NR4A3 | nuclear receptor subfamily 4, group A, member 3 | -0.0064 | 0.002 |
---|
38900_at | PAX3 | paired box gene 3 (Waardenburg syndrome 1) | 0.0051 | -0.0016 |
---|
1918_at | SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.005 | -0.0016 |
---|
979_g_at | BCL6 | B-cell CLL/lymphoma 6 (zinc finger protein 51) | 0.0042 | -0.0013 |
---|
1266_s_at | LCK | lymphocyte-specific protein tyrosine kinase | -0.0026 | 8e-04 |
---|
31604_at | GNAS | GNAS complex locus | 0.0022 | -7e-04 |
---|
1881_at | RUNX1 | runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | 0.0015 | -5e-04 |
---|
1744_at | CCND1 | cyclin D1 (PRAD1 | 0.0013 | -4e-04 |
---|
1728_at | BMI1 | B lymphoma Mo-MLV insertion region (mouse) | 8e-04 | -3e-04 |
---|
2020_at | CCND1 | cyclin D1 (PRAD1 | 6e-04 | -2e-04 |
---|
33862_at | PPAP2B | phosphatidic acid phosphatase type 2B | -4e-04 | 1e-04 |
---|
1807_g_at | MCF2 | MCF.2 cell line derived transforming sequence | -2e-04 | 1e-04 |
---|
35158_at | MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 2e-04 | -1e-04 |
---|
1745_at | RET | ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) | 2e-04 | 0 |
---|